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Aims: The aim of this study was to investigate the possible hypotensive and diuretic effects of 
ethanolic extract of Urtica circularis (Hicken) Sorarú (Urticaceae) using preclinical methods.  
Place and Duration of Study:  Department of Pharmacology, School of Pharmacy and 
Biochemistry, Universidad de Buenos Aires, from July 2015 to January 2016. 
Methodology:  Effect on blood pressure and heart rate on anaesthetized normotensive and 
hypertensive rats were measured using Statham Gould P23ID pressure transducer coupled to a 
Grass 79D polygraph. Rats were placed in metabolic cages in order to collect urine. Urinary volume 
was measured and sodium and potassium concentration was estimated from each urine sample 
using indirect ion-selective electrode potentiometry. The vasorelaxant activity of major compound 
was studied using isolated aortic rings. Antioxidant activity was estimated measuring 2,2 diphenyl 2 
picryl hydrazyl hydrate radical scavenging activity.  
Results:  The intravenous administration of the extract of U. circularis (0.1–30 mg/kg) in 











anaesthetized normotensive and hypertensive rats caused a dose-dependent reduction in the 
mean arterial pressure without affecting the heart rate. The greater reduction of blood pressure 
induced by U. circularis was observed in hypertensive rats (30 mg/kg: Spontaneously Hypertensive 
Rat: -34.7±3.3 mmHg, Spague Dawley: -18.3±3.9 mmHg). Cumulative urinary excretions 24 h after 
treatment with the extract 100 and 300 mg/kg were 18.2±1.2 and 14.9±1.5 mL respectively, 
significantly higher than the control group (9.0±1.3 mL). The addition of cumulative concentrations 
of vicenin-2 (10-7-10-4M) generated relaxation in endothelium-intact aortic rings pre-contracted with 
10–7M Phenylephrine (Emax = 66.2±3.5%). Extract showed antioxidant activity reaching 45% of 
DPPH scavenging activity at 1000 µg/mL, meanwhile the flavonoid reached 20% of scavenger 
capacity. 
Conclusion:  U. circularis, has a diuretic, antioxidant and hypotensive effect. Vicenin-2, the major 
component of this extract showed vasorelaxant activity, potentially responsible for the properties of 
the extract.   
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1. INTRODUCTION  
 
Hypertension, also known as high or raised blood 
pressure, is a global public health issue. 
Complications of hypertension account for 9.4 
million deaths worldwide every year. 
Hypertension is defined as a systolic blood 
pressure equal to or above 140 mm Hg and/or 
diastolic blood pressure equal to or above 90 mm 
Hg. Normal levels of both systolic and diastolic 
blood pressure are particularly important for the 
efficient function of vital organs such as the 
heart, brain and kidneys and for overall health 
and wellbeing. The higher the blood pressure, 
the higher the likelihood of harmful 
consequences to the heart and blood vessels in 
major organs such as the brain and kidneys. This 
is known as cardiovascular risk, and can also be 
high in people with mild hypertension in 
combination with other risk factors e.g., tobacco 
use, physical inactivity, unhealthy diet, obesity, 
diabetes, high cholesterol, low socioeconomic 
status and family history of hypertension [1].  
 
The renewed interest in the search for new drugs 
from natural sources, especially from plant 
sources, has gained global attention during the 
last two decades. This attention is primarily due 
to the rich biodiversity, which promises a high 
diversity of chemicals with the potential novel 
structures and promising effects. However, of 
this rich biodiversity, only a small portion has 
been studied for its medicinal potential. Thus, 
natural plants and herbs can be our source of 
drugs, with fewer side effects and better 
bioavailability for treatment of hypertension in 
future [2]. 
 
Urtica circularis (Hicken) Sorarú (Urticaceae) is 
an Argentinean native herb also distributed in 
Paraguay, Uruguay, and Brazil [3-5]. It is known 
with the common names of “ortiga”, “ortiga 
crespa”, “caá poropí”, and “urtiginha miúda” [3,6]. 
Extracts of this plant are popularly used in 
Argentina because of their diuretic and 
hypotensive effects and as a potion to lose 
weight [4]. It is also used as anti-inflammatory 
agent and against muscular pain [6]. Besides, it 
is employed for fertility, against hepatic 
problems, diarrhea, and to avoid hair loss [4]. In 
addition to its medicinal use, the plant is edible 
and considered to be highly nutritious for its 
minerals and vitamins content and it is usually 
included in different food preparations [4]. 
Previously, our group reported its anti-
inflammatory [7] and antinociceptive effects [8], 
and its activity in central nervous system [9]. No 
studies are available for its effects on blood 
pressure.    
 
Several species of Urtica genus are used for 
different conditions. Among them, the dried roots 
and rhizomes of Urtica dioica L. and Urtica urens 
L. are recommended by the World Health 
Organization for symptomatic treatment of lower 
urinary tract disorders (nocturia, polyuria, urinary 
retention) resulting from benign prostatic 
hyperplasia [1]. The aerial parts are used  
traditionally to increase the amount of urine to 
achieve flushing of the urinary tract as an 
adjuvant in minor urinary complaints [10] and as 
irrigation therapy for inflammatory diseases of 
the lower urinary tract and prevention and 
treatment of kidney gravel [11].  
 
Since other species such as U. dioica showed 
hypotensive and diuretic effects in preclinical 
models [12,13] and taking into account some of 
its popular uses and that no pharmacological 











U. circularis, the aim of this study was to 
evaluate its possible hypotensive and diuretic 
effects.  
 
2. MATERIALS AND METHODS  
 
2.1 Plant Material 
 
U. circularis (Hicken) Sorarú was collected in 
Estancia “La Merced”, Saladas Department, 
Corrientes, Argentina and identified by Dr Martha 
Gattuso. A voucher specimen (No. 054) is 
deposited in Facultad de Ciencias Químicas, 
Universidad Nacional de Rosario, Argentina. 
 
2.2 Extraction and Isolation 
 
The dried aerial parts of U. circularis were 
ground into a fine powder and extracted by 
maceration with 80% ethanol. The extract was 
concentrated and lyophilized (yield: 11.47%, 
w/w). The extract was dissolved in saline solution 
for intraperitoneal (i.p.) or intravenous (i.v.) 
administration. 
 
The HPLC method was developed, validated and 
performed with a Varian 9000 instrument using a 
diode array detector. A C18 column (Gemini 5 
µm, 150 x 4.6 mm) was used. Solvent A: 
H2O/AcOH (98:2); solvent B: MeOH/AcOH 
(98:2). Gradient: 15% B to 40% B, 30 min; 40% 
B to 75% B,10 min; 75% B to 85% B, 5 min.Flow 
rate:1.2mL/min. Detection: 325 nm. A Rheodyne 
injector fitted with a 20 µL loop was used. A 
major component of the extract was purified by 
preparative column chromatography in Sephadex 
LH20. The mobile phase was a gradient from 
CH2Cl2 (100%) to MeOH (100%). Afterward, 
preparative paper chromatography was 
performed on Whatman No. 3 using first 
nBuOH:AcOH:H2O, 4:1:1 (twice), and then water 
as solvents. The purity of the isolated compound 
was checked by HPLC analysis and was 97% on 
the basis of peak area integration. It was 
identified as vicenin-2 (5,7,40-trihydroxyflavone 
6,8-di-C-glucoside, 1, 0.08% w/w) by 
spectroscopic data measurement (UV-VIS, 1H 
NMR, ESIMS) and by comparison with literature 




Male Sprague-Dawley and hypertensive                 
(SHR: Spontaneously Hypertensive Rat) rats 
(200-220 g) were used according to international 
guiding principles and local regulations 
concerning care and use of laboratory animals 
for biomedical research (NIH Publication Nº 85-
23, Revised 1985). Animals had free access to a 
standard commercial diet and water ad libitum 
and were kept in room maintained at 22±1°C with 
12-h light/dark cycle. Experiments involving 
animals were approved by the Ethical Committee 
for the Care and Use of Laboratory Animals of 
School of Pharmacy and Biochemistry, 
Universidad de Buenos Aires (Ethics approval: 




Phenylephrine hydrochloride, indomethacin, L-
NG-Nitroarginine methyl ester, DPPH (2,2-
diphenyl-1-picrylhydrazyl) were purchased from 
Sigma (St. Louis, MO, USA). All chemicals used 
to prepare Krebs' solution were analytical grade 
and solubilized in distilled water. 
 
Vicenin-2 was previously isolated from                             
U. circularis [7]. The flavonoid solutions were 
prepared in dimethylsulfoxide (DMSO). The final 
concentration of DMSO was less than 0.05% 
which has been proven not to induce any 
observable effects on muscle tone. Indomethacin 
was dissolved in sodium bicarbonate (0.5%). All 
other drugs and solutions were prepared and 
used immediately. 
 
2.5 In vivo  Assays and Pharmacological 
Procedures 
 
2.5.1 Evaluation of the effects of U. circularis  
on blood pressure of anaesthetized rats  
 
Sprague-Dawley and SHR were anaesthetized 
with pentobarbital (40 mg/kg, i.p.) and allowed to 
breathe spontaneously through a tracheal 
cannula. A polyethylene catheter (PE50) was 
inserted into the femoral vein and a bolus 
injection of heparin (300 IU) was immediately 
administered. This venous access was used for 
i.v. injections. Another catheter was inserted into 
the carotid artery and connected to a Statham 
Gould P23ID pressure transducer coupled to a 
Grass 79Dpolygraph. The mean arterial pressure 
(MAP) was calculated according to the following 
formula:  
 
diastolic pressure + (systolic pressure –
diastolic pressure) / 3 
 
The heart rate (HR) was estimated 
tachographically by counting the pulsatile waves 
of arterial pressure recordings. After the surgery, 
a 30 min interval was allowed for MAP 
stabilization. Rats received extracts (0.1–30 











of U. circularis extract was administered 20 min 
after the previous injection (this interval was 
enough to warrant that the MAP would be back 
to normal levels). The U. circularis extract was 
diluted from a stock solution in sterile isotonic 
saline immediately before its administration [14]. 
Nifedipine (10 mg/kg) was used as reference 
drug. 
 
2.5.2 Effect on urinary volume and sodium 
excretion  
 
Diuretic activity was determined according to the 
method previously described [15], but with some 
modifications. For these experiments, rats were 
divided into four groups (n= 4) and fasted 
overnight for eighteen hours before testing, with 
free access to tap water only. Before treatment 
(30 min), all animals received an overload of 2 
mL / 100 g of water in an oral dose. 
Subsequently, rats were administered with  
extract (100 and 300 mg/kg), furosemide                      
(10 mg/kg) or saline solution by intraperitoneal 
route. Immediately after administration, the 
animals were placed in metabolic cages. Urine 
was collected in a graduated cylinder and its 
volume was measured and recorded 1, 2, 3, 4, 5 
and 24 h after treatment. Cumulative urine 
excretion was calculated. Sodium and potassium 
concentration was estimated from each urine 
sample using indirect ion-selective electrode 
potentiometry and expressed as mEq/L. The 
diuretic index (mean urinary volume of test 
group/ mean urinary volume of control group), 
saluretic index (concentration of electrolyte in 
urine of the test group/ concentration of 
electrolyte in urine of control group) were 
calculated. 
 
2.6 In vitro  Assays and Analytical 
Procedures 
 
2.6.1 Preparation of rat aortic rings  
 
Aortic rings were prepared as previously 
described [16]. Briefly, segments of the thoracic 
aorta from rats were excised. After removing 
adhering tissue, aorta was cut into 4-mm long 
rings and transferred to a dish filled with Krebs' 
solution (115.3 mM NaCl, 4.9 mM KCl, 1.46 mM 
CaCl2.2H2O, 1.2 mM KH2PO4, 1.2 mM MgSO4, 
11.1 mM D-glucose, 25 mM NaHCO3, pH 7.4). 
Rings were suspended in organ baths containing 
Krebs' solution bubbled with a carbogenic mix 
(5%CO2/ 95% O2) at 37°C. Isometric force 
transducers coupled to a Grass 79D polygraph 
were used to record contraction and relaxation. 
Preparations were maintained at a basal tension 
of 2 g and allowed to stabilize for 1h before 
addition of any drug. Control experiments, 
performed in the presence dimethylsulphoxide 
(DMSO) alone demonstrated that the solvent did 
not alter the contractile response of aortic rings. 
Endothelial integrity was verified by the ability of 
acetylcholine (1 µM ACh) to induce more than 
70% of relaxation on pre-contracted vessels.  
 
2.6.2 Measurement of vascular relaxation and 
assessment of the mechanisms 
involved  
 
The evaluation of the ability of vicenin-2, 
extracted from U. circularis, to cause                     
vascular relaxation was done in endothelium-
intact aortic rings previously contracted by 
Phenylephrine (Phe) (0.1 µM). Once the plateau 
was attained, under the sustained contraction, 
the vessels were exposed to cumulative 
concentrations of vicenin-2 (10-7-10-4M).                          
In a separated set of experiments using 
endothelium-intact rings the same procedure was 
performed in preparations incubated for 20 min in 
the presence of L-NG-Nitro arginine                      
methylester (L-NAME: 10 µM, a non-selective 
nitric oxide synthase inhibitor) and indomethacin 
(10 µM, a non-selective cyclooxygenase 
inhibitor).  
 
2.6.3 Assessment of 2, 2 diphenyl 2 picryl 
hydrazyl hydrate (DPPH) radical 
scavenging activity  
 
The scavenging activity of the extract and 
vicenin-2 on the stable free radical                       
DPPH was assayed using the modified                           
Blois’ method [17], in which the bleaching rate of 
DPPH is monitored at a characteristic 
wavelength in presence of the sample.                                
A volume of 0.1 mL of sample was mixed with 
0.5 mL of a 500 µM DPPH solution in                       
methanol and 0.4 mL of a 0.1 M Tris-HCl buffer, 
pH 7.4. The mixture was kept for 20 min in the 
dark and then the absorbance was read at 517 
nm. The percentage of decrease of DPPH 
absorbance was calculated by measuring the 
absorbance of the sample and applying the 
following equation:  
 
% of inhibition = [1-(As/A0)] x 100 
 
where As is absorbance of sample and                                  
A0 is the absorbance of the DPPH solution. 
Ascorbic acid solutions of different 
concentrations were used as positive controls for 
antioxidant activity. 
2.7 Statistical Analysis 
 
The pharmacological results are expressed as 
mean±SEM. Concentrations–response curves 
were plotted and experimental data were 
adjusted by a non-linear curve fitting program. 
Statistical analysis was performed by one
analysis of variance (ANOVA), followed by 
Bonferroni or Dunnet´ tests. P <.05 and
were considered to be statistically significant 




3.1 Phytochemical Studies  
 
In order to analyze the ethanol extract used in 
this study, HPLC was performed. A major peak 
at 24.2 min, was observed and it was identified 
as vicenin-2 by spectroscopic data measurement 
after isolation [7]. The corresponding fingerprint 
chromatogram is shown in Fig. 1. 
 
3.2 Effect on Arterial Pressure and Heart 
Frequency 
 
The i.v. administration of the extract o
U. circularis (0.1–30 mg/kg) in anaesthetized 
normotensive and hypertensive (SHR) rats 
caused a dose-dependent reduction in the mean 
arterial pressure (MAP) without affecting the 
heart rate (HR) (Fig.  2). It is interesting 
that the greater reduction of blood pressure 
induced by U. circularis was observed in 
Fig. 1. HPLC Chromatogram of the ethanol extract of  
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to note 
hypertensive rats (30 mg/kg: SHR: 
mmHg, Spague Dawley: -18.3±3.9 mmHg).  A 
single administration of nifedipine (10 mg/kg), a 
reference agent, induced  a   hypotensive  effect  
in   SHR  (∆MAP: 35 mmHg). 
 
3.3 Diuresis  
 
Intraperitoneal administration of the extract 
increased the urinary flow. The cumulative 
urinary excretions 24 h after treatment 
with the extract 100 and 300 
18.2±1.2 and 14.9±1.5 mL respectively. These 
values were significantly higher (
compared to the control group (9.0±1.3 mL). 
Therefore, U. circularis 100 and 300 mg/kg
led to a relative increase in cumulative diure
around 101% and 65%, respectively, 
compared to the control group. Furthermore, the 
diuretic index values of the test groups were 1.91 
and 1.61, which indicated a good diuretic 
activity in both doses. Meanwhile, reference drug 
group was 1.53. At dose of 300 mg/kg of 
extract the concentration of potassium and 
sodium excretions were similar compared
to the furosemide treated group. The saluretic 
index values showed an increase in the excretion 
of Na+ and K+ only in the higher dose of extra
and the reference drug group
U. circularis 100 mg/kg: 0.99; U. circularis
mg/kg: 1.61; furosemide 30 mg/kg: 1.44
Potasssium: U. circularis 100 m
U. circularis 300 mg/kg: 1.56; furosemide 30 
mg/kg: 1.63) (Fig. 3). 
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Fig. 2. Acute effect of the ethanol extract of  
U. circularis  (mg/kg i.v.) on mean arterial 
pressure (A) and heart rate (B) in 
anaesthetized normotensive and 
spontaneously hypertensive (SHR) rats  
Values are expressed as mean±SEM (n = 5). 
 * P<.01 versus basal measure (ANOVA) 
 
3.4 Effects of Vicenin-2 from U. circularis  
on Vascular Tonus 
 
The addition of cumulative concentrations of 
vicenin-2 (10-7-10-4M) generated relaxation in 
endothelium-intact aortic rings pre-contracted 
with 10–7M Phe (Emax = 66.2±3.5%). It was also 
found that the induced aortic relaxation by 
vicenin-2, was conserved after incubation with 
the indomethacin, but was reduced after 
incubation with L-NAME, suggesting nitric oxide 
pathway could be involved in its mechanism of 
action.   
 
3.5 Antioxidant Activity 
 
The scavenging activity of the extract and 
vicenin-2 was concentration dependent                              
as shown in Fig. 5 (A, B) The results indicate that                 
U. circularis’s extract showed antioxidant                           
activity reaching 45% of DPPH scavenging 
activity at 1000 µg/mL, meanwhile the                      
flavonoid reached 20% of scavenger                      
capacity. The ascorbic acid (control antioxidant 
drug) was shown in Fig. 5C. and it is                  





The main finding of the present study is                      
that the extract of U. circularis was able to 
reduce the blood pressure and induce                               
a diuretic effect in rats, representing the first 
attempt to describe the pharmacological 
evidences of antihypertensive effect of this 
extract. The method used in this study for blood 
pressure measurement was extensively used in 
the screening of cardiovascular effect of drugs 
[18]. The observed acute hypotensive                          
effect on normotensive rats indicates a direct 
action of its components on the cardiovascular 
system. Nevertheless, the extract does                             
not seem to affect the capacity of the heart to 
increase heart rate in order to compensate after 
the initial hypotension. Moreover, taking into 
account that SHR animals presents similar 
aspects with essential hypertension in humans, 
including genetic susceptibility, gradual 
development, and end-organ damage [19], 
antihypertensive activity of the extract could be 
demonstrated. 
 
The blood pressure is a product of cardiac output 
and vascular resistance and                     
hypertension is associated with vascular 
functional and structural changes including 
endothelial dysfunction, so the in vivo activity of 
the extract could be related to its effect on blood 
vessels. 
 
In this regard, the in vivo hypotensive                          
property of U. circularis could be substantiated 
by in vitro investigation on the isolated                           
aorta where the main compound showed 
vasorelaxant effect, suggesting that vicenin-2 
could be responsible, at least in part                                 
of the activity of the extract. Also, endothelial 
nitric oxide, an important signaling molecule, 
could participate in the relaxation induced                           
by the phytochemical. In agreement to our 
knowledge, this is the first time, that                        
vicenin-2 showed this activity. It was                          
described that this compound decreased 
acetylcholine or barium induced                             
contraction on intestinal smooth muscle [20], and 
attenuated vascular permeability, monocyte 
adhesion, activation of nuclear factor                               
NF-κB on high-glucose induced vascular 
inflammatory [21], but not the activity showed in 
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Fig. 3. Effect on urinary volume (A and B), sodium (C) and potassium (D) urinary levels of 
ethanol extract of U. circularis  (100 and 300 mg/kg), furosemide (30 mg/kg) and sal ine 
Values are expressed as mean±SEM. (n =5).* P<.05 and **P<.01 versus control group  




Fig. 4. Effect of L-NG-Nitro arginine 
methylester  and indomethacin on the 
relaxation induced by vicenin-2 in 
precontracted  aortic rings 
Values are expressed as mean ± SEM. (n = 4) 
 
The association between cardiovascular disease 
and renal impairment is well established and 
important. Furthermore, taking into account that 
diuretics remain as the preferred drugs for initial 
treatment in many hypertensive patients and that 
previous studies have established the 
hypotensive and diuretic effect of other species 
of Urtica after intravenous injection [12], the renal 
effect of the extract was evaluated. U. circularis 
showed diuretic index values greater than 1.5 in 
rats, hence, it is considered that the extract has a 
good diuretic activity [22]. Significant increase in 
urinary volume was observed not up to 3 h after 
administration, suggesting a slight delayed 
action, in contrast to furosemide, which acts 
within a relatively short time. Rise in the 
excretion of urinary electrolytes such as sodium 
and potassium was observed only at the higher 
dose of extract. Most diuretics enlarge the 
excretion of sodium and potassium, the 
exception being potassium-sparing diuretics, 
which increase the excretion of sodium but 
conserve potassium. These observations 
suggest that the extract is not acting as 
potassium-sparing diuretics, although more 
studies must be necessary to clear the 
mechanisms involved in its diuretic effects. 
 
Despite the diverse etiology of cardiovascular 
conditions, the enhanced production of ROS and 
altered oxygen utilization is apparently a 
common phenomenon and a participant in 
disease progression. Several antioxidants from 
natural sources have been proposed to prevent 
or reduce disease risk [23]. The DPPH method is 
widely used to test the ability of compounds to 
act as free radical scavengers or hydrogen 
donors, and to evaluate antioxidant capacity [24]. 
In this study, the extract and the main compound 
demonstrated free-radical-scavenging activity. 
Nevertheless, this activity was found to be lower 
than that of the reference natural antioxidant, 
ascorbic acid. But it is important to remark that 
since the oxidative stress leads to endothelial 
dysfunction by reducing NO bioavailability, the 
antioxidant activity of the extract and its main 
compound could collaborate in the beneficial 



















































































Fig. 5. DPPH scavenging activity of                              
U. circularis  extract (A), vicenin-2 (B) and 
ascorbic acid (C) 
 
Even though several medicinal plants have been 
described as promising hypotensive and diuretic 
agents like Artemisia copa, Artemisia herba alba, 
and other species of Urtica such as U. dioica 
[16,18,25], this is the first time that this ability 
was demonstrated by U. circularis. Furthermore 
this activity may be associated, at least in part, 




The results of the present study demonstrate that 
the ethanol extract of U. circularis, has a diuretic, 
antioxidant and hypotensive effect. As vicenin-2 
is the major component of this extract, this 
compound is potentially responsible for these 
properties. Vicenin-2 proved to possess 
vasorelaxant activity, through its effect on 
endothelial NOS.  
 
The effects showed in the present study supports 
the ethnomedical use of this plant and 
contributes to the scientific knowledge of the 
properties of our medicinal flora. And it could 









This work was supported by Grants from 










1. WHO. Monographs on selected medicinal 
plants. 2004;2:329-41.  
2. Baradaran A, Nasri H, Rafieian-Kopaei M. 
Oxidative stress and hypertension: 
Possibility of hypertension therapy with 
antioxidants. J Res Med Sci. 2014;19(4): 
358-67. 
3. Burkart A. Flora ilustrada de entre ríos. 
Sudamericana, Buenos Aires; 1987. 
(Spanish) 
4. Rondina R, Bandoni A, Coussio J. Plantas 
silvestres argentinas con reconocidas 
propiedades medicinales o tóxicas. 
segunda edición (CD-ROM). CYTED 
(Ciencia y Tecnología para el Desarrollo). 
Buenos Aires; 2003. (Spanish)   
5. Del Vitto L, Petenatti E, Petenatti M. 
Recursos herbolarios de San Luis 
(República Argentina) Primera parte: 
Plantas nativas. Multequina. 1997;6:      
49–66. (Spanish) 
6. Martínez Crovetto R. Plantas utilizadas en 
medicina en el noroeste de corrientes. 
miscelanea (Fundación Miguel Lillo), 











7. Marrassini C, Davicino R, Acevedo C, 
Anesini C, Gorzalczany S, Ferraro G. 
Vicenin-2, a potential anti-inflammatory 
constituent of Urtica circularis. J Nat Prod. 
2011;74(6):1503-7. 
8. Gorzalczany S, Marrassini C, Miño J, 
Acevedo C, Ferraro G. Antinociceptive 
activity of ethanolic extract and isolated 
compounds of Urtica circularis. J 
Ethnopharmacol. 2011;134(3):733-8. 
9. Anzoise ML, Marrassini C, Ferraro G, 
Gorzalczany S. Hydroalcoholic extract of 
Urtica circularis: A neuropharmacological 
profile. Pharm Biol. 2013;51(10):1236-42.  
10. European Medicines Agency (EMEA). 
Evaluation of medicines for human use. 
Assessment Report on Urtica dioica L. and 
Urtica urens L. Herba. Doc. Ref. EMEA/ 
HMPC/168380/2006; London. 2008;1-26. 
11. List of German Commission E 




(Accessed 09 September 2015) 
12. Tahri A, Yamani S, Legssyer A, Aziz M, 
Mekhfi H, Bnouham M, et al. Acute 
diuretic, natriuretic and hypotensive effects 
of a continuous perfusion of aqueous 
extract of Urtica dioica in the rat. J 
Ethnopharmacol. 2000;73(1-2):95-100. 
13. Testai L, Chericoni S, Calderone V, 
Nencioni G, Nieri P, Morelli I, et al.  
Cardiovascular effects of Urtica dioica L. 
(Urticaceae) roots extracts: in vitro and      
in vivo pharmacological studies. J 
Ethnopharmacol. 2002;81(1):105–109. 
14. Rattmann Y, Crestani S, Lapa F, Miguel O, 
Marques M, daSilva- Santos J, et al. 
Activation of muscarinic receptors by a 
hydroalcoholic extract of Dicksonia 
sellowiana Presl. HooK (Dicksoniaceae) 
induces vascular relaxation and 
hypotension in rats. Vascul Pharmacol. 
2009;50:27–33. 
15. Kau S, Keddi J, Andrews D. A method for 
screening diuretic agents in rats. J 
Pharmacol Method. 1984;11:67–75. 
16. Gorzalczany S, Moscatelli V, Ferraro G.  
Artemisia copa aqueous extract as 
vasorelaxant and hypotensive agent. J 
Ethnopharmacol. 2013;148:56–61.  
17. Blois M. Antioxidant determinations by the 
use of a stable free radical. Nature. 1958; 
181:1199–1200. 
18. Zeggwagh N, Michel J, Eddouks M. Acute 
hypotensive and diuretic activities of 
Artemisia herba alba aqueous extract in 
normal rats. Asian Pac J Trop Biomed. 
2014;4(2):S644-8. 
19. Pinto Y, Paul M, Ganten D. Lessons from 
rat models of hypertension: From goldblatt 
to genetic engineering. Cardiovasc Res. 
1988;39(1):77-88. 
20. Verspohl E, Fujii H, Homma K, Buchwald-
Werner S. Testing of Perilla frutescens 
extract and Vicenin-2 for their 
antispasmodic effect. Phytomedicine. 
2013;20(5):427-31. 
21. Ku S, Bae J. Vicenin-2 and scolymoside 
inhibit high-glucose-induced vascular 
inflammation in vitro and in vivo.                             
Can J Physiol Pharmacol. 2016;94(3):287-
95. 
22. Asif M, Jabeen Q, Majid A, Atif M.                     
Diuretic activity of aqueous extract of 
Nigella sativa in albino rats. Acta Pol. 
Pharm. Drug Research. 2015;72(1):129-
35. 
23. Wattanapitayakula S, Bauer J. Oxidative 
pathways in cardiovascular disease roles, 
mechanisms, and therapeutic implications. 
Pharmacol Ther. 2001;89(2):187–206. 
24. Karagöz A, Artun F, Özcan G, Melikoğlu G, 
Anıl S, Kültür S, et al. In vitro evaluation of 
antioxidant activity of some plant methanol 
extract. Biotechnol. Biotechnol. Equip. 
2015;29(6):1184-9.  
25. Kazama C, Uchida D, Canzi K, de Souza 
P, Crestani S, Gasparotto A, Laverde A. 
Involvement of arginine-vasopressin in the 
diuretic and hypotensive effects of 
Pereskia grandifolia Haw. (Cactaceae). J 
Ethnopharmacol. 2012;144:86–93. 
_________________________________________________________________________________ 
© 2016 Basso et al.; This is an Open Access article distributed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, 






The peer review history for this paper can be accessed here: 
http://sciencedomain.org/review-history/14180 
